KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer

Bibliographic Details
Main Authors:	Bar Julia K, Lis-Nawara Anna, Lebioda Arleta, Jonkisz Anna, Jeleń Michał, Dobosz Tadeusz
Format:	Article
Language:	English
Published:	BMC 2012-12-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/10/S4/A25

Similar Items

First successful DNA isolation and profiling from bone using an approach that is non-destructive toward bone surface
by: Dominika Pluta, et al.
Published: (2016-09-01)

Preliminary analysis of polymorphism of STR markers in the population of domestic cats (Felis catus) in Lower Silesia
by: Aneta Alama, et al.
Published: (2018-06-01)

Competitive amplification of differentially melting amplicons (CADMA) improves <it>KRAS</it> hotspot mutation testing in colorectal cancer
by: Kristensen Lasse, et al.
Published: (2012-11-01)

KRAS and TP53 mutations in colorectal carcinoma
by: Al-Kuraya Khawla
Published: (2009-01-01)

Mutational analysis of KRAS and NRAS in metastatic colorectal cancer
by: Romina Oliveira Silva
Published: (2019)

Novel KRAS gene mutations in sporadic colorectal cancer.
by: Walid M Naser, et al.
Published: (2014-01-01)

KRAS Gene Mutations and Gender Differences in Colorectal Cancer
by: Dmitriy I. Vodolazhskiy, et al.
Published: (2015-03-01)

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
by: Amanda K. Arrington, et al.
Published: (2012-09-01)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
by: Androulakis, N., et al.
Published: (2022)

Molecular understanding of KRAS- and BRAF-mutated colorectal cancers
by: Lundberg, Ida
Published: (2017)

Investigating the cooperation of APC and KRAS mutations in colorectal cancer
by: Gay, David Michael
Published: (2018)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction.
by: Reina E Ito, et al.
Published: (2021-01-01)

"Comparison of Methodologies for Kras Mutation Detection in Metastatic Colorectal Cancer".
by: Pinto, Pedro Miguel Teixeira
Published: (2011)

Spatial heterogeneity of KRAS mutations in colorectal cancers in northern France
by: Turpin A, et al.
Published: (2019-09-01)

Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab
by: Justine Bellier, et al.
Published: (2020-02-01)

The Possible Therapeutic Strategy for Colorectal Cancer with KRAS/BRAF Mutations
by: Jing-Jung Chen, et al.
Published: (2012)

Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology
by: Loretta László, et al.
Published: (2021-03-01)

BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.
by: Soo Kyung Nam, et al.
Published: (2016-01-01)

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
by: Bennani Fadel, et al.
Published: (2009-01-01)

ANALYSIS OF MUTATIONS IN KRAS AND BRAF GENES IN COLORECTAL CANCER IN RUSSIAN PATIENTS
by: E. E. Pisareva, et al.
Published: (2016-07-01)

Relationship of KRAS and PIK3CA gene mutation in colorectal cancer
by: Fan-Bao Yao, et al.
Published: (2016-05-01)

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder
by: Bohyun Kim, et al.
Published: (2016-01-01)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
by: Kim Mi-Jung, et al.
Published: (2012-08-01)

A novel method, digital genome scanning detects <it>KRAS </it>gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth
by: Yanagihara Kazuyoshi, et al.
Published: (2009-06-01)

KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer – practical implications for the clinician
by: Afrăsânie Vlad-Adrian, et al.
Published: (2019-09-01)

Predictive value of KRAS mutation and excision repair cross-complementing 1 (ERCC1) protein overexpression in patients with colorectal cancer administered FOLFOX regimen
by: Sun Min Park, et al.
Published: (2021-05-01)

Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
by: Erik J Blok, et al.
Published: (2013-02-01)

Cytoplasmic Overexpression of HER2: A Key Factor in Colorectal Cancer
by: Erik J Blok, et al.
Published: (2013-01-01)

KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan.
by: Muhammad Awidi, et al.
Published: (2019-01-01)

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
by: Daeyoun David Won, et al.
Published: (2017-06-01)

Global impact of KRAS mutations patterns in FOLFOX treated metastatic colorectal cancer
by: David eMolinas Zocche, et al.
Published: (2015-03-01)

KRAS mutations as a predictor of response to Cetuximab in metastatic colorectal cancer patients
by: Li-Chen Yen, et al.
Published: (2010)

Regulation of 18F-FDG Accumulation in Colorectal Cancer Cells with Mutated KRAS
by: Iwamoto, Masayoshi
Published: (2015)

Serotonin-Related Gene Variants in Patients with Irritable Bowel Syndrome and Depressive or Anxiety Disorders
by: Magdalena Grzesiak, et al.
Published: (2017-01-01)

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
by: Swenerton Kenneth D, et al.
Published: (2009-12-01)

Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases
by: Gabriele Zoppoli, et al.
Published: (2017-05-01)

HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer
by: Luo H, et al.
Published: (2021-04-01)

Assessment of HER2 Protein Overexpression and Gene Amplification in Renal Collecting Duct Carcinoma: Therapeutic Implication
by: Manuela Costantini, et al.
Published: (2020-11-01)

Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification.
by: Masahiro Itonaga, et al.
Published: (2016-01-01)

KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection
by: Olga I. Brovkina, et al.
Published: (2021-03-01)

Cannot write session to /tmp/vufind_sessions/sess_pkokcb1o0hbtjbjneqn3ckt40p